Carboplatin-Etoposide Combination in Hormone-Resistant Prostate Cancers

NCT00973882 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Carboplatin
DRUG: Etoposide

Sponsor

Centre Leon Berard